May 15, 2025

The nonprofit foundation’s $75 million designation to the campaign reinforces its decades-long partnership with Michigan State University, advancing research, innovation, and student success through strategic funding over the next eight years.

May 13, 2025

Indapta Therapeutics reports 90%+ tumor marker reduction in early trials—without the dangerous side effects of CAR T-cell therapies.

May 12, 2025

Dr. Mark Frohlich never set out to build a lean [...]

May 5, 2025

When Bruno Basso stepped off the plane in Michigan as [...]

May 5, 2025

In this episode, we talk with Dr. Mark Frohlich, CEO of Indapta Therapeutics, a biotech company working to make cancer treatment safer, more effective, and more accessible.

April 28, 2025

In a world awash with data, the most valuable innovations [...]